Mark Bouzyk

Mark Bouzyk is a biotechnology executive, scientist, and entrepreneur with over 30 years of experience advancing genetics, genomics, and precision medicine across global pharmaceutical companies, academic institutions, and high-growth biotech startups. His work spans pharmacogenomics, oncology, biomarker discovery, and digital health, and he is dedicated to translating scientific innovation into practical clinical solutions.

Mark has held senior leadership roles at SmithKline Beecham and GlaxoSmithKline, where he built and led large-scale genetics laboratories, high-throughput genotyping operations, and global sample-management infrastructures supporting major pharmacogenetic and disease-association studies. His contributions supported early research that helped shape genetic testing practices in drug safety.

He later joined the faculty at Emory University, directing genomics, biomarker, and cancer research centers and fostering collaboration across core laboratories.